These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5162006)

  • 1. The effect of nonaqueous solvents on the quaternary structure of viruses: a procedure for the simultaneous concentration, purification and disruption of influenza viruses.
    Neurath AR; Rubin BA; Sillaman J; Tint H
    Microbios; 1971 Sep; 4(14):145-50. PubMed ID: 5162006
    [No Abstract]   [Full Text] [Related]  

  • 2. Temperature optima of neuraminidase activity of influenza viruses.
    Golubev DB; Aptekareva MN; Ivanova NA; Bykov SE; Ivannikov YG
    Acta Virol; 1973 Jul; 17(4):281-6. PubMed ID: 4148206
    [No Abstract]   [Full Text] [Related]  

  • 3. Two-step centrifugation method. A simplification of the density-gradient procedure for the purification of influenza virus.
    Arora DJ; Pavilanis V; Robert P
    Can J Microbiol; 1973 May; 19(5):633-8. PubMed ID: 4736197
    [No Abstract]   [Full Text] [Related]  

  • 4. The "in vivo" production of "new" influenza A viruses. I. Genetic recombination between avian and mammalian influenza viruses.
    Webster RG; Campbell CH; Granoff A
    Virology; 1971 May; 44(2):317-28. PubMed ID: 5565817
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and concentration of influenza inactivated viruses by continuous-flow zonal centrifugation.
    Mistretta AP; Crovari-Cuneo P; Giacometti G; Sacchi G; Strozzi F
    Boll Ist Sieroter Milan; 1975; 54(1):45-56. PubMed ID: 1125111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of guanidine hydrochloride and heat on the haemagglutinin and neuraminidase of influenza viruses.
    David-West TS; Belyavin G
    Arch Gesamte Virusforsch; 1973; 43(4):367-76. PubMed ID: 4799156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of influenza virus A 2 -Hongkong and A 2 -Asia].
    Frey WR
    Pathol Microbiol (Basel); 1972; 38(3):167-77. PubMed ID: 5065133
    [No Abstract]   [Full Text] [Related]  

  • 8. Simple method for the concentration of influenza virus from allantoic fluid on microporous filters.
    Goyal SM; Hanssen H; Gerba CP
    Appl Environ Microbiol; 1980 Mar; 39(3):500-4. PubMed ID: 7387152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus titrations and the inhibitor of hemagglutination in normal allantoic fluid.
    Orthel FW
    Arch Gesamte Virusforsch; 1972; 38(4):347-56. PubMed ID: 5083408
    [No Abstract]   [Full Text] [Related]  

  • 10. [Methodological bases for obtaining subunit vaccines].
    Vasil'eva GA
    Tr Inst Im Pastera; 1982; 59():129-33. PubMed ID: 7187565
    [No Abstract]   [Full Text] [Related]  

  • 11. The polypeptides of influenza virus. 8. Large-scale purification of the hemagglutinin.
    Stanley P; Crook NE; Streader LG; Davidson BE
    Virology; 1973 Dec; 56(2):640-5. PubMed ID: 4796551
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic hybrids of influenza A viruses with surface antigens to order.
    Webster RG
    Virology; 1970 Nov; 42(3):633-42. PubMed ID: 5529980
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic structure of influenza A viruses; an immunodiffusion study.
    Styk B; Blaskovic D; Hána L; Jakubka J; Sedíleková M
    Acta Virol; 1970 May; 14(3):194-208. PubMed ID: 4392919
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza vaccines purified by zonal ultracentrifugation.
    Filczak K; Semkow R; Wrzos H; Zakrzewski K; Zgorzelska K
    Acta Microbiol Pol A; 1973; 5(3):261-70. PubMed ID: 4769561
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification and aggregation of influenza virus by precipitation with polyethylene glycol.
    Polson A
    Prep Biochem; 1974; 4(5):435-56. PubMed ID: 4438275
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of cell culture respiration by influenza virus strains of different virulence.
    Voitsekhovsky BL; Polyak RY
    Acta Virol; 1972 Jul; 16(4):313-22. PubMed ID: 4403173
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental selection of influenza virus mutants (subtype A0 and A1): haemagglutinin.
    Cinco M; Rottini G; Pagan F
    Zentralbl Bakteriol Orig A; 1973 Oct; 224(4):413-21. PubMed ID: 4150106
    [No Abstract]   [Full Text] [Related]  

  • 18. Occurence of unstability of hemagglutinin and neuraminidase in cells infected with different myxoviruses.
    Gribkova NV; Kaverin NV; Tsvetkova IV; Lipkind MA
    Arch Gesamte Virusforsch; 1973; 43(1):98-102. PubMed ID: 4799981
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of neuraminidase from hemagglutinins caused by treatment of influenza viruses with ether. (Brief report).
    Neurath AR; Rubin BA; Hartzell RW
    Arch Gesamte Virusforsch; 1969; 28(3):421-3. PubMed ID: 5386786
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral effect of 1-aminoadamantane derivatives in vitro.
    Váczi L; Hankovszky H; Hideg K; Hadházy G
    Acta Microbiol Acad Sci Hung; 1973; 20(3):241-7. PubMed ID: 4361336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.